| 2018-09-28 | variant's name changed from c.[1210-34TG[9];1210-12T[9]]] to c.1210-34_1210-6TG[9]T[9] |
Variant NM_000492.4:c.1210-34_1210-6TG[9]T[9]
| Name | NM_000492.4:c.1210-34_1210-6TG[9]T[9] |
| #Exon/intron | intron 9 |
| Legacy Name | TG9T9 |
| Class | non disease-causing |
| complex allele in 15.91% of patients associated with |
![]() Not found | ![]() Not found | dbSNP no rs |
![]() Not found | ![]() Not found |
No patient found in CFTR-NGS catalogue |
| TOTAL NUMBER OF PATIENTS | 44 |
|---|---|
| CF | 6 |
| CFTR-RD | 28
|
| Pending | 1 |
| Pending (NBS) | 9 |
| Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
| Phenotype | Patient ID | Variant status | Additional variants |
|---|---|---|---|
| CBAVD | 6466 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
| CBAVD | 1163 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
| CBAVD | 1056 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
| CBAVD | 5221 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
| CBAVD | 1413 | heterozygote | CFTR-RD-causing - Trans varying clinical consequence- Undef |
| CBAVD | 4592 | heterozygote | varying clinical consequence - Cis CFTR-RD-causing - Trans |
| CBAVD | 1438 | heterozygote | CFTR-RD-causing - Trans varying clinical consequence- Undef |
| CBAVD | 978 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
| CBAVD | 912 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
| CBAVD | 491 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
| CBAVD | 490 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
| CBAVD | 434 | heterozygote | varying clinical consequence - Cis CF-causing - Trans |
| CBAVD | 548 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
| CBAVD | 583 | heterozygote | CFTR-RD-causing - Trans VUS3- Undef |
| CBAVD | 881 | heterozygote | CFTR-RD-causing - Trans varying clinical consequence- Undef |
| CBAVD | 857 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
| CBAVD | 840 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
| CBAVD | 834 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
| CBAVD | 765 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
| CBAVD | 643 | heterozygote | CFTR-RD-causing - Trans varying clinical consequence- Undef |
| CBAVD | 614 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
| CBAVD | 4679 | heterozygote | varying clinical consequence - Cis CF-causing - Trans |
| Bronchiectasis | 1096 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
| Bronchiectasis | 4602 | heterozygote | CFTR-RD-causing - Trans varying clinical consequence- Undef |
| Bronchiectasis | 4726 | heterozygote | CFTR-RD-causing- Undef varying clinical consequence- Undef |
| Pending (NBS) | 4769 | heterozygote | CF-causing - Trans varying clinical consequence- Undef |
| Pending (NBS) | 1180 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
| Pending (NBS) | 5342 | heterozygote | varying clinical consequence - Cis CF-causing - Trans |
| Pending (NBS) | 6457 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
| Pending (NBS) | 4654 | heterozygote | varying clinical consequence - Cis CF-causing - Trans |
| Pending (NBS) | 1547 | heterozygote | varying clinical consequence - Cis CF-causing - Trans |
| Pending (NBS) | 4821 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
| Pending (NBS) | 799 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
| Pending (NBS) | 794 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
| CF | 4782 | heterozygote | varying clinical consequence - Cis CF-causing - Trans |
| CF | 5132 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
| CF | 5622 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
| CF | 313 | heterozygote | CF-causing- Undef CFTR-RD-causing- Undef varying clinical consequence- Undef |
| CF | 280 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
| CF | 277 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
| Pending | 312 | heterozygote | CFTR-RD-causing - Trans |
| Other | 5813 | heterozygote | CFTR-RD-causing- Undef varying clinical consequence- Undef |
| Pancreatitis | 1063 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
| Pancreatitis | 3259 | heterozygote | varying clinical consequence- Undef CF-causing- Undef |
| Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
| CFTR variants are clustered into five groups (click here for more details about the classification of variants): |
|